Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for the Treatment of Vitiligo

NCT05577637 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Vitiligo

Interventions

DRUG: 0.03% tacrolimus twice daily was applied on group A patients with uvb phototherapy thrice daily

Sponsor

Combined Military Hospital Abbottabad